Cargando…

Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulation

INTRODUCTION: Widespread use of generic drugs is considered to be indispensable if reductions in total health care costs are to be achieved, but the market share of such drugs remains low. In general, generic drugs have the same active ingredients as brand-name drugs, but this is not always the case...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ochi, Nobuaki, Yamane, Hiromichi, Hotta, Katsuyuki, Fujii, Hiromi, Isozaki, Hideko, Honda, Yoshihiro, Yamagishi, Tomoko, Kubo, Toshio, Tanimoto, Mitsune, Kiura, Katsuyuki, Takigawa, Nagio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262375/ https://www.ncbi.nlm.nih.gov/pubmed/25584019 http://dx.doi.org/10.2147/DDDT.S71419

Ejemplares similares

Twenty-Seven Years of Phase III Trials for Patients with Extensive Disease Small-Cell Lung Cancer: Disappointing Results
por: Oze, Isao, et al.
Publicado: (2009)

Mechanisms of Acquired Resistance to ALK Inhibitors and the Rationale for Treating ALK-positive Lung Cancer
por: Isozaki, Hideko, et al.
Publicado: (2015)

Rapid on-site evaluation with BIOEVALUATOR(®) during endobronchial ultrasound-guided transbronchial needle aspiration for diagnosing pulmonary and mediastinal diseases
por: Minami, Daisuke, et al.
Publicado: (2014)

Treatment-Related Death in Patients with Small-Cell Lung Cancer in Phase III Trials over the Last Two Decades
por: Ochi, Nobuaki, et al.
Publicado: (2012)

Downregulation of TBXAS1 in an iron-induced malignant mesothelioma model
por: Minami, Daisuke, et al.
Publicado: (2015)

Role of Survival Post-Progression in Phase III Trials of Systemic Chemotherapy in Advanced Non-Small-Cell Lung Cancer: A Systematic Review
por: Hotta, Katsuyuki, et al.
Publicado: (2011)

Docetaxel for non-small-cell lung cancer harboring the activated EGFR mutation with T790M at initial presentation
por: Yamane, Hiromichi, et al.
Publicado: (2013)

Endobronchial ultrasound-guided transbronchial needle aspiration of hilar and mediastinal lymph nodes detected on (18)F-fluorodeoxyglucose positron emission tomography/computed tomography
por: Minami, Daisuke, et al.
Publicado: (2016)

Magnitude of the Benefit of Progression-Free Survival as a Potential Surrogate Marker in Phase 3 Trials Assessing Targeted Agents in Molecularly Selected Patients with Advanced Non-Small Cell Lung Cancer: Systematic Review
por: Hotta, Katsuyuki, et al.
Publicado: (2015)

Crizotinib for recurring non‐small‐cell lung cancer with EML4‐ALK fusion genes previously treated with alectinib: A phase II trial
por: Harada, Daijiro, et al.
Publicado: (2021)

Circulating thymus and activation-regulated chemokine/CC chemokine ligand 17 is a strong candidate diagnostic marker for interstitial lung disease in patients with malignant tumors: a result from a pilot study
por: Yamane, Hiromichi, et al.
Publicado: (2015)

Obstructive jaundice at the initial presentation in small-cell lung cancer
por: Ochi, Nobuaki, et al.
Publicado: (2010)

Epiphora in lung cancer patients receiving docetaxel: a case series
por: Yamagishi, Tomoko, et al.
Publicado: (2014)

High Uptake of FDG Along a Biliary Stent
por: Nagasaki, Yasunari, et al.
Publicado: (2016)

The Role of STAT3 in Non-Small Cell Lung Cancer
por: Harada, Daijiro, et al.
Publicado: (2014)

Obstructive jaundice caused by intraductal metastasis of lung adenocarcinoma
por: Ochi, Nobuaki, et al.
Publicado: (2014)

Brand Name Versus Generic?
por: Aungaroon, Gewalin
Publicado: (2023)

Acute necrotizing encephalopathy in an adult with influenza A infection
por: Ochi, Nobuaki, et al.
Publicado: (2018)

Erythema as a Visual Surrogate Marker of Glucagonoma
por: Ochi, Nobuaki, et al.
Publicado: (2018)

Efficacy of multimodal treatment for leptomeningeal metastases in a lung cancer harboring an EGFR mutation
por: Morichika, Daisuke, et al.
Publicado: (2016)

Drug-induced interstitial lung disease in the treatment of malignant lymphoma as a potential diagnostic marker: a comparison of serum Krebs von Lungen-6 and thymus and activation-regulated chemokine/CC chemokine ligand 17
por: Yamane, Hiromichi, et al.
Publicado: (2018)

Herpetic esophagitis following bendamustine-containing regimen
por: Yamane, Hiromichi, et al.
Publicado: (2016)

Congestive Heart Failure During Osimertinib Treatment for Epidermal Growth Factor Receptor (EGFR)-mutant Non-small Cell Lung Cancer (NSCLC)
por: Watanabe, Hiromi, et al.
Publicado: (2017)

“Engagement ring” image conveys regrettable outcome for aged patients with non‐small cell lung cancer
por: Yamane, Hiromichi, et al.
Publicado: (2018)

Patients with osteosarcoma and soft tissue sarcoma might become “cancer refugees” in some Japanese regional cities
por: Yamane, Hiromichi, et al.
Publicado: (2018)

Whole Blood Interferon-Gamma Assay for Baseline Tuberculosis Screening among Japanese Healthcare Students
por: Hotta, Katsuyuki, et al.
Publicado: (2007)

Histological comparison between preoperative and surgical specimens of non-small cell lung cancer for distinguishing between "squamous" and "non-squamous" cell carcinoma
por: Yamagishi, Tomoko, et al.
Publicado: (2014)

Ceftriaxone-associated pancreatitis captured on serial computed tomography scans
por: Nakagawa, Nozomu, et al.
Publicado: (2017)

The concept of: Generic drugs and patented drugs vs. brand name drugs and non-proprietary (generic) name drugs
por: Thakkar, Karan B., et al.
Publicado: (2013)

Generic versus brand-name drugs used in cardiovascular diseases
por: Manzoli, Lamberto, et al.
Publicado: (2015)

Generics versus brand-named drugs for glaucoma: the debate continues
por: Bhartiya, Shibal, et al.
Publicado: (2020)

A phase I/II trial of weekly nab‐paclitaxel for pretreated non‐small‐cell lung cancer patients without epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangement
por: Harada, Daijiro, et al.
Publicado: (2019)

Successful palliation for an aged patient with primary pericardial mesothelioma
por: Isoda, Ryutaro, et al.
Publicado: (2015)

Chest computed‐tomography 1 day before the diagnosis of coronavirus disease 2019
por: Yamane, Hiromichi, et al.
Publicado: (2023)

Safety of switching from brand-name to generic levetiracetam in patients with epilepsy
por: Bosak, Magdalena, et al.
Publicado: (2017)

Elemental impurities analysis in name-brand and generic omeprazole drug samples
por: Pinheiro, Fernanda C., et al.
Publicado: (2020)

Comparison of Pharmaceutical Characteristics between Brand-Name Meropenem and Its Generics
por: Yang, Ping, et al.
Publicado: (2021)

Pneumocystis Pneumonia Concomitant with Ectopic ACTH Syndrome Caused by a Large Cell Neuroendocrine Carcinoma of the Thymus
por: Oda, Naohiro, et al.
Publicado: (2017)

What’s in a Name? Use of Brand versus Generic Drug Names in United States Outpatient Practice
por: Steinman, Michael A., et al.
Publicado: (2007)

The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?
por: Sarpatwari, Ameet, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cab5n3c081upmtm0qruao6pikq